Trial intelligence / Profile preview

Midodrine Dose Response for Orthostatic Hypotension in SCI

NCT00426842Phase 2Completed

Sponsor
James J. Peters Veterans Affairs Medical Center
Start
Jan 2007
Primary completion
Mar 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-blind, single-arm trial of midodrine in orthostatic hypotension (OH), sponsored by James J. Peters Veterans Affairs Medical Center. Primary endpoint: Systolic Blood Pressure Response. Started Jan 2007; status: completed.

02

Drugs

midodrine
03

Conditions

orthostatic hypotension (OH)

Beyond the preview

Go deeper on NCT00426842.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00426842.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call